Effect of the Substitution of One Nucleoside Analogue by One Non-nucleoside Reverse Transcriptase Inhibitor over Mitochondrial DNA Levels

被引：0

作者：

B. De Felipe

A. Blanco

N. Soriano-Sarabia

M. Á. Muñoz-Fernández

M. Genebat

A. Vallejo

M. Leal

机构：

[1] Virgen del Rocío University Hospital,Service of Infectious Diseases

[2] Gregorio Marañón General University Hospital,Laboratory of Immunobiology

[3] Virgen del Rocío University Hospital,Laboratory of Immunovirology, Service of Internal Medicine

[4] Virgen del Rocío University Hospital,Laboratory of Molecular Virology

[5] Hospital Universitario Virgen del Rocio,Laboratory of Immunovirology, Service of Infectious Diseases

来源：

Infection | 2008年 / 36卷

关键词：

Nucleoside Analogue; Nucleoside Reverse Transcriptase Inhibitor; Mitochondrial Toxicity; Lipodystrophy Syndrome; Detectable Plasma Viral Load;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：266 / 270

页数：4

共 50 条

[1] Effect of the substitution of one nucleoside analogue by one non-nucleoside reverse transcriptase inhibitor over mitochondrial DNA levels
De Felipe, B.
Blanco, A.
Soriano-Sarabia, N.
Munoz-Fernandez, M. A.
Genebat, M.
Vallejo, A.
Leal, M.
[J]. INFECTION, 2008, 36 (03) : 266 - 270
[2] Toxicity of non-nucleoside analogue reverse transcriptase inhibitors
Kontorinis, N
Dieterich, DT
[J]. SEMINARS IN LIVER DISEASE, 2003, 23 (02) : 173 - 181
[3] Interactions between non-nucleoside reverse transcriptase inhibitor and nucleoside reverse transcriptase inhibitor mutations: phenotypes and mechanisms
Shulman, Nancy S.
[J]. CURRENT OPINION IN HIV AND AIDS, 2007, 2 (02) : 88 - 93
[4] Rilpivirine: a new non-nucleoside reverse transcriptase inhibitor
Sharma, Mamta
Saravolatz, Louis D.
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (02) : 250 - 256
[5] Rilpivirine: a novel non-nucleoside reverse transcriptase inhibitor
Garvey, Lucy
Winston, Alan
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2009, 18 (07) : 1035 - 1041
[6] Nucleoside reverse transcriptase inhibitor toxicity and mitochondrial DNA
Koczor, Christopher A.
Lewis, William
[J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2010, 6 (12) : 1493 - 1504
[7] Complete remission of AIDS/Kaposi's sarcoma after treatment with a combination of two nucleoside reverse transcriptase inhibitors and one non-nucleoside reverse transcriptase inhibitor
Murdaca, G
Campelli, A
Setti, M
Indiveri, F
Puppo, F
[J]. AIDS, 2002, 16 (02) : 304 - 305
[8] Synthesis of Some Novel Non-Nucleoside Reverse Transcriptase Inhibitor
Bapna, Mayank
Nema, R. K.
[J]. ASIAN JOURNAL OF CHEMISTRY, 2009, 21 (02) : 1244 - 1248
[9] HIV-1 non-nucleoside reverse transcriptase inhibitor
Lloyd, AW
[J]. DRUG DISCOVERY TODAY, 1998, 3 (08) : 387 - 387
[10] Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naive individuals
Spaulding, Alicen
Rutherford, George W.
Siegfried, Nandi
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (10):

← 1 2 3 4 5 →